Oncolys BioPharma Inc. 4588Short Interest
Estimated short interest in Oncolys BioPharma Inc. (4588) is 10.35% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Barclays Capital Securities Ltd, GOLDMAN SACHS INTERNATIONAL, Morgan Stanley MUFG Securities Co., Ltd. and 4 others.
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 2 institutions whose last report is more than a year old (2.17% in total). It also excludes 19 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-08-29 |
|---|---|
| Latest disclosure | 2026-11-17 (Morgan Stanley MUFG Securities Co., Ltd., 1.36%) |
| Reporting institutions | 29 firms (4063 reports) |
| Peak estimated short interest | 20.98% (2025-12-15, 11 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- GOLDMAN SACHS INTERNATIONAL
- Morgan Stanley MUFG Securities Co., Ltd.
- JPM Securities Japan Co Ltd.
- UBS AG
- Others
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-16 | Barclays Capital Securities Ltd | Position 1,284,416 shares | Ratio 4.34% | ▲0.19% | Holding |
| 2024-08-15 | Segregated Portfolio D | Position 333,600 shares | Ratio 1.49% | ▼0.10% | No report for 1+ year |
| 2026-11-11 | GOLDMAN SACHS INTERNATIONAL | Position 412,438 shares | Ratio 1.39% | ▼0.09% | Holding |
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 403,393 shares | Ratio 1.36% | ▼0.10% | Holding |
| 2026-11-16 | JPM Securities Japan Co Ltd. | Position 370,123 shares | Ratio 1.25% | ▲0.15% | Holding |
| 2026-11-16 | UBS AG | Position 239,000 shares | Ratio 0.80% | ▲0.07% | Holding |
| 2026-11-16 | Nomura International plc | Position 210,324 shares | Ratio 0.71% | ▲0.46% | Holding |
| 2017-10-10 | JPMorgan Securities Japan Co., Ltd. | Position 75,400 shares | Ratio 0.68% | ▼0.03% | No report for 1+ year |
| 2026-08-17 | Bronte Capital Management Pty Ltd | Position 148,300 shares | Ratio 0.50% | ▲0.03% | Holding |
| 2021-04-19 | Deutsche Bank Aktiengesellschaft, London | Position 86,400 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2020-09-01 | JANE STREET GLOBAL TRADING, LLC | Position 72,100 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2021-09-24 | Arrowstreet International Equity ACWI ex US Alpha Extension Trust Fund | Position 85,700 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-06-08 | BNP Paribas Financial Markets SNC | Position 145,200 shares | Ratio 0.49% | ▼0.07% | Below 0.5% |
| 2026-10-01 | PDT Partners, LLC | Position 145,500 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-06-04 | Nomura Securities Co., Ltd. | Position 141,630 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2025-12-22 | Two Sigma Absolute Return Portfolio, LLC | Position 143,442 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2026-11-10 | Citigroup Global Markets Limited | Position 141,300 shares | Ratio 0.47% | ▼0.70% | Below 0.5% |
| 2026-07-24 | Arrowstreet Capital, Limited Partnership | Position 138,700 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2022-02-08 | Credit Suisse AG | Position 80,700 shares | Ratio 0.46% | ▼0.04% | Below 0.5% |
| 2026-06-16 | Jump Trading Pacific Pte Ltd | Position 136,500 shares | Ratio 0.46% | ▼0.08% | Below 0.5% |
| 2025-10-16 | Man Solutions Limited | Position 114,100 shares | Ratio 0.42% | ▼0.15% | Below 0.5% |
| 2019-12-19 | Credit Suisse Securities (Europe) Limited | Position 56,900 shares | Ratio 0.40% | ▼0.43% | Below 0.5% |
| 2022-03-25 | Arrowstreet International Equity - Alpha Extension Fund | Position 64,800 shares | Ratio 0.37% | ▼0.13% | Below 0.5% |
| 2018-12-18 | OXAM QUANT FUND LIMITED | Position 45,300 shares | Ratio 0.34% | ▼0.32% | Below 0.5% |
| 2019-07-24 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 47,000 shares | Ratio 0.33% | ▼0.27% | Below 0.5% |
| 2025-03-25 | XTX Markets Pte Ltd | Position 84,000 shares | Ratio 0.33% | ▼0.18% | Below 0.5% |
| 2019-12-10 | Credit Suisse Securities (Japan) Limited | Position 41,400 shares | Ratio 0.29% | ▼0.40% | Below 0.5% |
| 2025-04-03 | MERRILL LYNCH INTERNATIONAL | Position 55,700 shares | Ratio 0.22% | ▼0.29% | Below 0.5% |
| 2026-10-30 | Jane Street Asia Trading Limited | Position 38 shares | Ratio 0.00% | ▼0.51% | Closed |
Disclosure History 4063 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 403,393 shares | Ratio 1.36% | ▼0.10% | — |
| 2026-11-16 | UBS AG | Position 239,000 shares | Ratio 0.80% | ▲0.07% | — |
| 2026-11-16 | Nomura International plc | Position 210,324 shares | Ratio 0.71% | ▲0.46% | — |
| 2026-11-16 | JPM Securities Japan Co Ltd. | Position 370,123 shares | Ratio 1.25% | ▲0.15% | — |
| 2026-11-16 | Barclays Capital Securities Ltd | Position 1,284,416 shares | Ratio 4.34% | ▲0.19% | — |
| 2026-11-13 | Nomura International plc | Position 74,300 shares | Ratio 0.25% | ▼0.36% | Below 0.5% |
| 2026-11-13 | JPM Securities Japan Co Ltd. | Position 326,323 shares | Ratio 1.10% | ▲0.23% | — |
| 2026-11-13 | Barclays Capital Securities Ltd | Position 1,230,316 shares | Ratio 4.15% | ▼0.68% | — |
| 2026-11-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 432,504 shares | Ratio 1.46% | ▼0.12% | — |
| 2026-11-12 | Nomura International plc | Position 181,841 shares | Ratio 0.61% | ▲0.33% | — |
| 2026-11-12 | JPM Securities Japan Co Ltd. | Position 259,023 shares | Ratio 0.87% | ▼0.12% | — |
| 2026-11-11 | UBS AG | Position 218,700 shares | Ratio 0.73% | ▼0.37% | — |
| 2026-11-11 | GOLDMAN SACHS INTERNATIONAL | Position 412,438 shares | Ratio 1.39% | ▼0.09% | — |
| 2026-11-11 | Barclays Capital Securities Ltd | Position 1,428,885 shares | Ratio 4.83% | ▲0.50% | — |
| 2026-11-10 | Nomura International plc | Position 128,850 shares | Ratio 0.43% | ▼0.07% | Below 0.5% |
| 2026-11-10 | GOLDMAN SACHS INTERNATIONAL | Position 439,738 shares | Ratio 1.48% | ▼0.21% | — |
| 2026-11-10 | Citigroup Global Markets Limited | Position 141,300 shares | Ratio 0.47% | ▼0.70% | Below 0.5% |
| 2026-11-10 | Barclays Capital Securities Ltd | Position 1,281,885 shares | Ratio 4.33% | ▲0.64% | — |
| 2026-11-10 | Morgan Stanley MUFG Securities Co., Ltd. | Position 467,329 shares | Ratio 1.58% | ▼0.11% | — |
| 2026-11-09 | UBS AG | Position 328,000 shares | Ratio 1.10% | ▲0.24% | — |
| 2026-11-09 | JPM Securities Japan Co Ltd. | Position 295,423 shares | Ratio 0.99% | ▼0.04% | — |
| 2026-11-09 | GOLDMAN SACHS INTERNATIONAL | Position 501,838 shares | Ratio 1.69% | ▼0.03% | — |
| 2026-11-09 | Citigroup Global Markets Limited | Position 348,500 shares | Ratio 1.17% | ▼0.30% | — |
| 2026-11-09 | Barclays Capital Securities Ltd | Position 1,092,985 shares | Ratio 3.69% | ▲0.42% | — |
| 2026-11-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 502,729 shares | Ratio 1.69% | ▼0.05% | — |
| 2026-11-06 | UBS AG | Position 255,200 shares | Ratio 0.86% | ▼0.04% | — |
| 2026-11-06 | GOLDMAN SACHS INTERNATIONAL | Position 509,738 shares | Ratio 1.72% | ▼0.12% | — |
| 2026-11-06 | Citigroup Global Markets Limited | Position 435,700 shares | Ratio 1.47% | ▼0.14% | — |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 969,585 shares | Ratio 3.27% | ▲0.36% | — |
| 2026-11-05 | UBS AG | Position 267,400 shares | Ratio 0.90% | ▲0.03% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
| Renascience Inc.4889 | 6.87% | 3 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| SymBio Pharmaceuticals Limited4582 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chiome Bioscience Inc.4583 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kidswell Bio Corporation4584 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Medrx Co.,Ltd.4586 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PeptiDream Inc.4587 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| RIBOMIC Inc.4591 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SanBio Company Limited4592 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| HEALIOS K.K.4593 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| BrightPath Biotherapeutics Co.,Ltd.4594 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| MIZUHO MEDY CO.,LTD.4595 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical |